Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

BIAXIN Drug Profile

« Back to Dashboard
Biaxin is a drug marketed by Abbvie and is included in three NDAs. It is available from eight suppliers. There are two patents protecting this drug and one Paragraph IV challenge.

The generic ingredient in BIAXIN is clarithromycin. There are twenty-one drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the clarithromycin profile page.

Summary for Tradename: BIAXIN

Suppliers / Packagers: see list8
Drug Prices: :see details

Clinical Trials for: BIAXIN

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
TABLET;ORAL050662-001Oct 31, 1991RXYes
TABLET, EXTENDED RELEASE;ORAL050775-001Mar 3, 2000DISCNNo6,551,616Jun 15, 2017
FOR SUSPENSION;ORAL050698-003Sep 30, 1998DISCNNo
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: BIAXIN

Drugname Dosage Strength RLD Submissiondate
clarithromycinExtended-release Tablet500 mgBiaxin XL12/6/2010
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.